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Introduction
The primary treatment for untreated nasopharyngeal carcinoma (NPC) is
radiotherapy (RT) alone for early-stage lesion and concurrent chemo-radiation
for advanced tumor. Suarez et al. (2010), Ma et al. (2001), and Lin, Liang,
Jan, Jiang, and Lin (2004) reported that incidence of local recurrence was
approximately 8% to 58%. You et al. (2015) mentioned locally recurrent NPC
can be treated with salvage reirradiation or surgery. Ridge (1993) recom-
mended that resection of locally discrete recurrent NPC should be considered
unless the patient is unfit for surgery. Tumors that persist or recur after pri-
mary radiotherapy have demonstrated significant resistance to radiotherapy.
Surgery should be considered for patients presenting with residual or recur-
rent tumor after radiotherapy or chemoradiotherapy, and for patients with
glandular or mesenchymal differentiated tumors that are poorly responsive to
radiotherapy as mentioned by Al-Sheibani et al. (2011). Furthermore, high
dose reirradiation may still result in severe complications like osteoradionecro-
sis, brain necrosis, radiation induced myelitis, hypopituitarism and trismus as
described by To et al. (2002) and Chang et al. (2000).
Nasopharyngectomy is a well-established surgical procedure for salvaging locally
recurrent NPC; via various surgical approaches, that is, midfacial degloving,
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transpalatal, transmaxillary, maxillary swing, or transmandibular as mentioned by
King, Ku, Mok, and Teo (2000). The common complications for open nasophar-
yngectomy are middle ear effusion, palatal fistula, nasal regurgitation and trismus.
Ideally, a surgical approach to the nasopharynx should provide adequate
visualization of the tumor margins, allow complete oncologic resection with
negative margins, allow the possibility to extend the resection margins if nec-
essary, and allow the identification and protection of important neurovascular
structures. In addition, it should avoid facial scarring or deformity, preserve
neurologic and masticatory functions, and facilitate the reconstruction of the
surgical defect. Over the past decade, the evolution of these approaches has
incorporated endoscopic endonasal techniques to complement conventional
skull base approaches, and in certain patients, as the sole approach.
Endoscopic endonasal transpterygoid nasopharyngectomy (EETN) has then
emerged as a viable treatment option for locally recurrent NPC with minimal
invasiveness, avoiding morbidity from external approaches and the absence of
facial scar. A literature review by Emanuelli et al. (2014) showed that endo-
scopic method attained a higher negative surgical margin of 93.75% than
external approach (71.6%).
Radical neck dissection or modified radical neck dissection should be performed
for regional recurrence of NPC at the neck, provided there is no distant metas-
tasis. Either unilateral or bilateral neck dissections are performed depending on
the extent of the nodal disease.
Patient selection
Patient selection is perhaps the most important aspect of effectively treating
patients with EETN. Generally speaking, patients categorized as rT1, those cate-
gorized as rT2 with minimal parapharyngeal extension, and select patients cate-
gorized as rT3 (Involvement of floor of sphenoid sinus) can be treated with
EETN as described by Chen et al. (2012). Exclusion criteria for patients are
based on disease factors and patient factors. Disease factors include significant
parapharyngeal space extension, internal carotid artery (ICA) involvement, cav-
ernous sinus with multiple cranial nerves involvement, brain parenchymal
involvement and presence of distant metastasis. Patient factors include patients
who are medically unfit to tolerate surgery and undergo general anesthesia.
Preoperative workup
All patients who undergo EETN will have thorough preoperative workup. The
preoperative workup includes clinical factors, radiological factors, and patholog-
ical factors.
For clinical factors, patients require a thorough medical examination including
nasopharyngoscopy to delineate the tumor extension. The patient’s full medical
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status must also be investigated to determine eligibility for general anesthesia.
For radiological factors, radiological examination is essential to ascertain the
extent of the primary tumor, assess for regional lymph node involvement, and
rule out distant metastatic disease. Investigational techniques include com-
puted tomography and magnetic resonance imaging (MRI), and occasionally
positron emission tomography scan. For pathological factors, histopathological
examination of the suspected local recurrence or residual tumor and type of
tumor must be confirmed before any surgical intervention.
Special attention has to be given to ascertain the relationship of the tumor to
the parapharyngeal and petrous segments of the ICA. Generally, patients with
tumors that are encasing the ICA and, extensive dura or intradural involvement
are not suitable candidates for EETN. Other important preoperative prepara-
tions depending on the individual case include computed tomography angiog-
raphy (CTA) with computed tomography and MRI fusion for intraoperative
navigation. An acoustic Doppler ultrasound probe can complement the surgical
navigation device for the identification of critical vessels, especially ICA. The
preferred prophylactic perioperative antibiotic regimen should include a third-
generation cephalosporin with cerebral spinal fluid penetration.
Surgical technique
The surgery is done under general anesthesia with the patient lying in supine
position. The nasal cavities are decongested with Moffett’s solution for 30 minutes
as illustrated by Benjamin, Wong, and Choa (2004). The solution contains 1 mL
adrenaline 1:1000, 2 mL of 10% cocaine, 4 mL of 8.4% sodium bicarbonate,
mixed together with 13 mL of water for injection. Following general anesthesia,
there is widespread vasodilation, hence producing hyperemic mucosa. A topical
decongestant of Moffett’s solution could reduce nasal blood flow, optimizing the
surgical field. Infiltration of both middle turbinates and nasal septum with a
solution of lidocaine 1% and epinephrine 1/100,000 enhances the hemostasis.
Surgery proceeds via a purely endoscopic endonasal approach using a 0- and
30-degree rod lens endoscope. A fundamental premise of the endonasal
endoscopic approach is that two surgeons work concomitantly, using a
bimanual, three-/four-handed technique via both nostrils and nasal cavities.
This facilitates dynamic visualization as well as bimanual dissection, which is
vital for depth perception, traction, countertraction, and for maintenance of
a blood-free surgical field.
Sinonasal corridor
Firstly, surgery is initiated by enlarging the natural sinonasal corridor ipsilateral
to the lesion by removing the inferior half of the right middle turbinate and
completing an uncinectomy, large midmeatal nasomaxillary window, and ante-
rior and posterior ethmoidectomies. This increases the working space and
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expose the entire posterior wall of the antrum. A medial maxillectomy is per-
formed to expose the entire height of the posterior wall of the maxillary sinus
and to allow an extended dissection of the pterygopalatine fossa. This medial
maxillectomy is limited anteriorly by the nasolacrimal duct, which acts like a ful-
crum point, preventing free movement of the scope laterally. Endoscopic
Denker’s approach (also known as the SturmanCanfield approach) can be
performed to further increase the lateral angle of exposure and optimize instru-
ment maneuverability. Endoscopic Denker’s approach is a procedure to remove
the piriform aperture, as well as the anterior maxillary wall, until the lateral wall
of the antrum is in direct and full view especially viewing the entire infratem-
poral fossa (Fig. 11.1).
Additional lateral control is obtained by bringing the instruments from the con-
tralateral side of the nose through a posterior septectomy. A generous posterior
bony septectomy allows a bimanual technique traversing both sides of the
nasal cavity. This extensive posterior septectomy allows visualization of the
entire posterior wall of the maxillary sinus using a 0-degree endoscope that
crosses over to the contralateral side of the nose.
Nasoseptal flap
The HadadBassagasteguy nasoseptal flap (HBF) should be harvested from the
contralateral side of the tumor as illustrated by Al-Sheibani et al. (2011). It is
critical to harvest the HBF from the contralateral side because its pedicle and
proximal blood supply would be surrendered ipsilateral to the transpterygoid
dissection. Later, a Caicedo reverse flap is transposed from the contralateral
side to cover the HBF donor defect as illustrated by Prosser, Figueroa, Carrau,
Ong, and Solares (2011). Clinical harvesting of these septal flaps presumes that
the tumor does not involve this area. If tumor involves the nasal septum, other
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Inferior sphenoidectomy
The anterior face of the sphenoid sinus is often opened early during the
approach, enlarging the sphenoid ostium after completing the ethmoidec-
tomies. As the superior part of the sphenoid crest is removed, the sella turcica’s
floor and intersinus and intrasinus septations, as well as the lateral walls of the
sphenoid sinus, come into direct view. Prior to removing the inferior compo-
nent of the sphenoid rostrum, its mucoperiosteum is dissected laterally and
inferiorly to identify key anatomic landmarks as this area comprises the pedicle
of the HBF as described by Hadad et al. (2006).
The lateral walls of the sphenoid and the medial pterygoid plates (lateral wall of
the posterior choana) form a vertical strut that intersects the floor of the sphe-
noid sinus. The junction of the vertical medial pterygoid plate with the horizon-
tal floor of the sphenoid sinus forms a wedge-shaped area (“pterygoid wedge”)
that contains both the vidian canal and the palatovaginal canal. After complete
removal of the vomer, the intersinus septum, and the sphenoid sinus floor, the
sphenoidectomy should extend superiorly to be in plane with the roof of the
nose and laterally to be in plane with the laminae papyracea bilaterally as
described by Caicedo-Granados et al. (2010). Complete removal of the sphe-
noid sinus floor is performed until the cavity is flush with the clivus (Fig. 11.6).
Pterygopalatine fossa dissection
Dissection of the soft tissue contents of the pterygopalatine fossa is a prerequi-
site for the transpterygoid approach. After exposing the entire posterior maxil-
lary sinus wall via medial maxillectomy, the sphenopalatine and posterior nasal
arteries are divided at the level of the sphenopalatine foramen. Removal of the
posterior wall of the antrum and the ascending process of the palatine bone
exposes the pterygopalatine fossa with its intrinsic and bordering foramina and
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Transpterygoid dissection
A transpterygoid dissection starts with the identification of the vidian nerve
proximal to the pterygopalatine ganglion, as it exits from the vidian canal. The
vidian nerve can be localized following the palatovaginal canal laterally or by
drilling its canal starting at the pterygoid wedge. The vidian nerve, within the
pterygoid canal, courses toward the second genu of the ICA between the hori-
zontal and vertical segments. For the most part, the vidian canal remains infe-
rior to the second genu of the ICA; therefore initial drilling in a 39 o’clock
orientation, helps to prevent injury to the ICA. In some cases, the superior
aspect of the canal is covered just with a very thin bone or may even be dehis-
cent, thus exposing the nerve in the floor of the sphenoid sinus.
The maxillary division of the trigeminal nerve passes through the foramen rotun-
dum as it courses from Meckel’s cave into the pterygopalatine fossa as described
by Fortes et al. (2008). The maxillary nerve can also be identified in its canal cours-
ing the lateral wall of the sphenoid sinus. The pharyngeal end of the Eustachian
tube or torus tubarius is just posterior to the pterygoid process. Removal of the
pterygoid process exposes the cartilaginous Eustachian tube. The parapharyngeal
segment of the ICA is posterior to the Eustachian tube in most of the cases.
All these landmarks are crucial to identify during the transpterygoid approach
before tumor extirpation (Figs. 11.7 and 11.8).
Tumor extirpation
Tumor removal begins by marking out at least 1 cm margin if technically possible
around the tumor. The mucosal cuts are made with needlepoint electrocautery,
which helps with hemostasis. The superior and posterior dissection occurs by ele-
vating the mucoperiosteum from the floor of the sphenoid sinus and the clivus
posteriorly. Monteiro and Witterick (2014) mentioned the dissection proceeds
inferiorly to the level of the soft palate, until the prevertebral musculature deep to
Figure 11.6
Drilling anterior
wall and floor of
the sphenoid
sinus.
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the pharyngobasilar fascia and prevertebral fascia is encountered. Electrocautery
or Kerrison rongeurs both can be used, and are effective at removing portions of
the prevertebral muscle and fascia, as these structures are quite resilient. The mus-
cles are included in the en-bloc resection if involved with malignancy.
Laterally, the medial pterygoid plate and pterygoid process are exposed,
above which lies the sinus of Morgagni, through which passes the Eustachian
tube and tensor veli palatine muscle. These structures can be excised along
with the levator palatini muscle to expose the parapharyngeal tissues as men-
tioned by Kassam et al. (2009). The mucosa is elevated off the base of the
foramen lacerum and continues anteriorly toward the posterior aspect of the
fossa of Rosenmuller. The Eustachian tube cartilage laterally is identified and
included in the specimen. As the dissection proceeds laterally, the Doppler
probe is used to map out the ICA, thereby reducing the likelihood of inadver-
tent injury. Following complete tumor removal, margin status is confirmed by
sending circumferential and deep margins for frozen section analysis
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Nasopharyngeal reconstruction
Yip et al. (2013) described reconstruction with a vascularized pedicle flap at the
nasopharyngeal defect facilitates the healing of the defect, resists irradiation,
and protects the ICA against exposure and blowout. The nasoseptal flap or HBF
is rotated into the nasopharyngeal defect. The edges of the flap are allied well
to cover the bare area especially exposed bony portion at the clivus.
Absorbable gelatin sponges are placed on the flap, and a Foley catheter is used
to support the nasoseptal flap against the nasopharyngeal defect. In cases
where the nasoseptal flap is unavailable, a lateral nasal wall flap can be har-
vested for reconstruction. Other reconstructive options include healing by sec-
ondary intention or the use of regional flaps such as pedicled temporoparietal
fascia flap (Figs. 11.11 and 11.12).
Following reconstruction, the nasal cavity is thoroughly inspected for hemosta-
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reversed from general anesthesia and transferred to the postoperative care unit
for recovery. The patient is admitted to a standard ward unit and is usually dis-
charged from hospital within 23 days.
Postoperative care and
complications
Patients are generally seen every 23 weeks to undergo endoscopic examina-
tion. During these clinic procedures, decrusting is performed, paying careful
attention not to disrupt the nasoseptal flap or any other flaps that are laid on.









the flap at place.
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nasal rinses 34 times per day. They may experience a significant amount of
postoperative crusting requiring frequent endoscopic debridement until ree-
pithelialization occurs. This process can take up to 3 or more months, even
with a nasoseptal flap. Postoperative headache is a common complaint follow-
ing EETN due to exposed bone. Exposed bone covered with a pedicled naso-
septal flap reduces this incidence significantly.
Serous otitis media is another common complication encountered in the post-
operative period. This can be managed by myringotomy with tympanostomy
tube insertion or amplification with hearing aids.
Postoperative epistaxis can occur secondary to bleeders that are not secured
during the surgery especially when the nasoseptal flap is not in used, and the
bleeding is from the posterior septal artery. Other possible surgical sequelae
include xerophthalmia secondary to injury of the vidian nerve, numbness in the
V2 distribution, skull base injury including cerebrospinal fluid leak, and injury to
the ICA in either its parapharyngeal, petrous, or clival portions as described by
Valentine and Wormald (2011).
Conclusion
In conclusion, EETN is a feasible approach for the surgical treatment of selected
primary and recurrent nasopharyngeal tumors. The surgical technique requires
a trained and experienced team with specialized instruments. This technique
shows relatively low morbidity with promising preliminary outcomes and local
control of the disease that is comparable to conventional techniques.
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